Comparative safety of percutaneous ventricular assist device and intra-aortic balloon pump in acute myocardial infarction-induced cardiogenic shock.
Waqas UllahMohammad ZghouziMaryam MukhtarAli BanisadGaith AlhatemiYasar SattarSalman ZahidHomam Moussa PachaDelair GardiM Chadi AlraiesPublished in: Open heart (2021)
In patients with acute myocardial infarction complicated by cardiogenic shock, there is no significant difference in the adjusted risk of all-cause mortality, major bleeding, stroke and limb ischaemia between the devices. Randomised trials are warranted to investigate further the safety and efficacy of these devices in patients with cardiogenic shock.
Keyphrases
- acute myocardial infarction
- left ventricular
- atrial fibrillation
- percutaneous coronary intervention
- clinical trial
- heart failure
- high glucose
- open label
- catheter ablation
- diabetic rats
- aortic valve
- double blind
- pulmonary artery
- ultrasound guided
- study protocol
- radiofrequency ablation
- endothelial cells
- pulmonary hypertension